CNS Pharmaceuticals Inc Sustainability Reports
CNS Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing novel treatments for primary and metastatic brain and central nervous system cancers.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 529900FDJ7WGF2Q7UN44
1 reports from 2023 to 2023
Company Profile
CNS Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing novel treatments for primary and metastatic brain and central nervous system cancers.
Reports
1 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
Years
